- The trend backdrop is active with a 71-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
HSX
LSE
Week ended 07 Aug 2026
Weekly Investor Report
Hiscox Ltd · Financial Services · Insurance - Property & Casualty
Latest close
1,829 GBP
1.1%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 11.2% above the Trend Line and sits at 88.4% of its 52-week range. The latest completed week returned 1.1%, after a -1.5% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers. The latest news-sentiment score is 57/100.
Setup score
73
out of 100
Latest Close
1,829 GBP
7 Aug 2026
1W Return
1.1%
latest completed week
4W Return
-1.5%
short-term follow-through
12W Return
-0.7%
quarterly tape
Trend Breadth
100.0%
52 of 52 weeks active
Volume Ratio
3.4x
vs 13-week average
- 2 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.1%
Latest completed week; four-week move -1.5%.
Indicator stack
100/62
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
57/100
26 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 11.2% above the Trend Line and sits at 88.4% of its 52-week range. The latest completed week returned 1.1%, after a -1.5% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 3.4x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.8612-week average 0.93
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.86Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -1.5% over four weeks, -0.7% over 12 weeks, and 35.2% over one year. The current trend has remained active for 71 consecutive weeks.
Performance by holding period
Active trend streak71 weeks
Active weeks in one year52
Trend breadth100.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.81Latest activity-pressure read.
Pressure change-27.9%Four-week change in activity pressure.
Leadership11.18Latest relative-leadership reading.
RS change-40.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Dec 2025
Field coverage 82%
Model confidence 65%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength76/100Blend of value, momentum, and quality. Underlying universe rank 25; rank 1 is best.
Value86/100Relative valuation strength. Underlying universe rank 15; rank 1 is best.
Quality9/100Profitability and accounting quality. Underlying universe rank 92; rank 1 is best.
Momentum92/100Medium-term price momentum. Underlying universe rank 9; rank 1 is best.
Growth17/100Revenue and earnings growth. Underlying universe rank 84; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 9.7x Price divided by trailing earnings.
- Price / sales
- 1.5x Market value relative to trailing revenue.
- EV / EBITDA
- 6.8x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 0.4% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- - Gross profit retained from each unit of revenue.
- Operating margin
- 20.2% Operating profit retained from revenue.
- Free-cash-flow margin
- 0.7% Free cash flow generated from revenue.
- Return on invested capital
- 15.1% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 7.5% Latest one-year revenue growth.
- EPS growth
- 1.1% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -64.9% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 3/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 2.0% Cash dividends relative to market value.
- Buyback yield
- 4.6% Net share repurchases relative to market value.
- Shareholder yield
- 6.7% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.0x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment57/100
Weighted news tone is neutral across 26 relevant articles.
10 positive · 16 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-3.9%Distance below the 52-week high.
13-week volatility4.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher15 of 2611 weeks finished lower.
Best week+13.4%Week of 15 May.
Worst week-5.6%Week of 6 Mar.
Latest week+1.1%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains11
Flat weeks0
Modest losses9
Sharp losses2
Recent vol4.1%13-week weekly-return volatility.
Base vol3.2%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew2.8% / -1.9%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorGB Financial Services
4-week rank81 / 100
Group average2.1%
Trend breadth60.0%
Trend60.0%active weekly trend signals
MD68.0%positive activity pressure
RS53.0%positive relative leadership
Four-week leaders
IndustryGB Insurance - Property & Casualty
4-week rank2 / 3
Group average1.3%
Trend breadth100.0%
Trend100.0%active weekly trend signals
MD100.0%positive activity pressure
RS100.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape77/100
Trend, activity pressure, participation, and risk combine to a 77/100 tape read.
Indicator analysis85/100Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.86; 2 reversal markers Factors63/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 14 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment57/100Weighted news tone is neutral across 26 relevant articles.
Hiscox grows 10.1% in H1 2026 but non-renews 23% of power and renewables book Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 1,829 GBP | 1.1% | 1,645 GBP | 1,258 GBP | 0.81 | 11.18 | 17.9M | On |
| 31 Jul 2026 | 1,809 GBP | -1.7% | 1,631 GBP | 1,253 GBP | 0.95 | 10.57 | 7.1M | On |
| 24 Jul 2026 | 1,840 GBP | -2.0% | 1,617 GBP | 1,248 GBP | 1.10 | 14.23 | 6.1M | On |
| 17 Jul 2026 | 1,877 GBP | 1.1% | 1,604 GBP | 1,243 GBP | 1.20 | 18.45 | 5.2M | On |
| 10 Jul 2026 | 1,856 GBP | 0.1% | 1,589 GBP | 1,238 GBP | 1.12 | 18.79 | 3.6M | On |
| 3 Jul 2026 | 1,854 GBP | -0.2% | 1,572 GBP | 1,234 GBP | 1.09 | 17.23 | 458.8K | On |
| 26 Jun 2026 | 1,857 GBP | 4.3% | 1,554 GBP | 1,228 GBP | 0.94 | 19.83 | 938.7K | On |
| 19 Jun 2026 | 1,780 GBP | 1.1% | 1,536 GBP | 1,223 GBP | 0.93 | 16.95 | 2.2M | On |
| 12 Jun 2026 | 1,761 GBP | 2.6% | 1,521 GBP | 1,219 GBP | 1.14 | 14.91 | 923.4K | On |
| 5 Jun 2026 | 1,717 GBP | -1.8% | 1,508 GBP | 1,215 GBP | 1.33 | 13.51 | 1.5M | On |
| 29 May 2026 | 1,749 GBP | -3.7% | 1,497 GBP | 1,211 GBP | 1.45 | 15.37 | 5.6M | On |
| 22 May 2026 | 1,816 GBP | -1.4% | 1,484 GBP | 1,207 GBP | 1.23 | 19.52 | 8.5M | On |
| 15 May 2026 | 1,841 GBP | 13.4% | 1,469 GBP | 1,203 GBP | 1.08 | 24.87 | 8.7M | On |
| 8 May 2026 | 1,624 GBP | 4.8% | 1,453 GBP | 1,199 GBP | 1.02 | 10.39 | 4.7M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.